IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SIMONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.709
NA - Nord America 2.360
AS - Asia 899
AF - Africa 32
SA - Sud America 23
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.232
GB - Regno Unito 1.181
CN - Cina 403
IT - Italia 360
SE - Svezia 325
DE - Germania 308
SG - Singapore 143
CA - Canada 122
FI - Finlandia 115
KR - Corea 105
IE - Irlanda 77
HK - Hong Kong 74
FR - Francia 61
IN - India 58
RU - Federazione Russa 53
UA - Ucraina 49
TR - Turchia 48
DK - Danimarca 41
EU - Europa 40
BE - Belgio 32
NG - Nigeria 28
PL - Polonia 28
NL - Olanda 27
JP - Giappone 23
AU - Australia 17
ID - Indonesia 15
CO - Colombia 14
ES - Italia 11
CZ - Repubblica Ceca 9
VN - Vietnam 8
GR - Grecia 7
TW - Taiwan 7
IL - Israele 6
RO - Romania 6
BG - Bulgaria 5
BR - Brasile 5
AT - Austria 4
CI - Costa d'Avorio 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
MX - Messico 3
CL - Cile 2
HN - Honduras 2
MD - Moldavia 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 6.085
Salva come PNG Salva come JPEG
Città #
Southend 1.087
Chandler 331
Houston 177
Ashburn 169
Fairfield 164
Wilmington 157
Seattle 142
Milan 132
Ann Arbor 117
Princeton 113
Woodbridge 102
Toronto 100
Beijing 85
Singapore 82
Dublin 75
Helsinki 64
Hong Kong 62
Nanjing 45
Phoenix 43
Cambridge 38
Grafing 38
Mountain View 37
Redmond 36
Bengaluru 32
Boardman 31
Des Moines 31
Dearborn 29
Lekki 28
Shanghai 28
Warsaw 28
Jinan 27
Brussels 25
Shenyang 25
Somerville 23
Redwood City 21
Guangzhou 20
Bitonto 19
Sakarya 19
Hangzhou 18
Norwalk 18
Andover 17
New York 17
Ottawa 17
Seongnam 17
Frankfurt am Main 16
Medford 15
Bogotá 14
Kiez 14
Nanchang 14
Eitensheim 13
Changsha 12
Jacksonville 12
Hebei 11
Jakarta 11
Ningbo 11
Serra 11
Hamburg 10
Roxbury 10
San Diego 10
Zhengzhou 10
Brno 9
Los Angeles 9
Silver Spring 9
Hanover 8
Falls Church 7
Rome 7
Seoul 7
Tianjin 7
Athens 6
Taizhou 6
Wako 6
Berlin 5
Bridge 5
Cagliari 5
Columbia 5
Durham 5
Mumbai 5
Suwon 5
Taipei 5
Tel Aviv 5
Tokyo 5
Abidjan 4
Bogen 4
Catania 4
Central 4
Chicago 4
Dong Ket 4
Florence 4
Fremont 4
Huntington Station 4
Kilburn 4
Margão 4
Nutley 4
Pskov 4
Tappahannock 4
Turin 4
Wembley 4
Auburn Hills 3
Chengdu 3
Hefei 3
Totale 4.284
Salva come PNG Salva come JPEG
Nome #
GENERAZIONE E CORREZIONE DI CELLULE STAMINALIPLURIPOTENTI INDOTTE NON VIRALI DA PAZIENTE SMA COMEMODELLO DI MALATTIA E SORGENTE PER LA TERAPIA CELLULARE 325
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 319
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 235
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 229
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 219
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 193
Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives 184
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives 180
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS 173
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 169
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? 169
Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS 155
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development 148
Embryonic stem cell–derived neural stem cells improve spinal muscular atrophy phenotype in mice 136
Direct reprogramming of human astrocytes into neural stem cells and neurons 135
Therapeutic Development in Amyotrophic Lateral Sclerosis 135
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 133
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases 133
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy 130
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 119
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 114
Neural stem cells derived from genetically engineered lineage-selectable Es cells improves the phenotype of a mouse model of spinal muscular atrophy 106
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 106
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 105
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms 103
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 103
Pluripotent engineered stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice 101
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 100
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms 98
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells 98
Directing human astrocytes into neural stem cells and neurons as possible tool for repair in CNS diseases 98
Neuroprotection in spinal muscular atrophy (SMA) using neural stem cells as a therapeuthic approach 97
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 96
Motor neurons from human spinal muscular atrophy–induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 96
Transplantation of neural stem cells derived from genetically engineered, lineage-selectable ES cells improves spinal muscular atrophy 94
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis 94
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis 93
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 93
Gene Corrected Spinal Muscular Atrophy-Induced Pluripotent Stem Cells and Motoneuron as a Model and Cell Source for Transplantation (IN8-2.002) 93
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA) 92
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 89
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 89
Molecular therapeutic strategies for spinal muscular atrophies : Current and future clinical trials 89
Motoneurons from human spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 89
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives 88
Systemic transplantation of c-kit+ cells can ameliorate the phenotype of a mouse model of Amyotrophic Lateral Sclerosis 79
Generation of motoneurons from spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences : in vitro and In vivo analysis 78
Pluripotent stem cell-based models of spinal muscular atrophy 77
Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation 72
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review 69
In vitro and in vivo analysis of motoneurons obtained from human-spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences 68
null 4
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Totale 6.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.638
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020941 94 33 54 89 77 76 56 95 181 114 51 21
2020/2021695 33 31 49 20 62 60 85 60 79 33 114 69
2021/2022766 45 64 24 47 40 54 39 25 127 86 62 153
2022/2023934 124 124 85 107 110 153 26 52 108 12 25 8
2023/2024633 21 38 36 68 149 68 21 33 25 33 55 86
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 6.517